Treatment practices of mild cognitive impairment in California Alzheimer's Disease Centers (Q37411298)

20 August 2017

Treatment practices of mild cognitive impairment in California Alzheimer's Disease Centers (English)

1 reference

mild cognitive impairment

20 August 2017

0 references

0 references

1 reference

inferred from title

cognitive dysfunction

1 reference

5

Kristine Yaffe

1 reference

20 August 2017

1

Andrea M Weinstein

1 reference

20 August 2017

Cynthia Barton

2

1 reference

20 August 2017

Leslie Ross

series ordinal

3

1 reference

20 August 2017

Joel H Kramer

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

Journal of the American Geriatrics Society

20 August 2017

1 reference

20 August 2017

57

1 reference

20 August 2017

4

1 reference

20 August 2017

686-690

1 reference

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Statin therapy in Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Vitamin E and donepezil for the treatment of mild cognitive impairment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Treating the full spectrum of dementia with memantine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Statins for the reduction of risk of Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Mild cognitive impairment: clinical characterization and outcome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Safety and efficacy of galantamine in subjects with mild cognitive impairment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Plasma folate concentration and cognitive performance: Rotterdam Scan Study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Subtype of mild cognitive impairment and progression to dementia and death

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773021

Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19392962

12 December 2020

inferred from PubMed ID database lookup

Blessed-Roth Dementia Scale (DS)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19392962

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1532-5415.2009.02200.X

1 reference

release_o6zoyqghgbe4ldksyurlbuvosm

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o6zoyqghgbe4ldksyurlbuvosm

24 November 2022

mapped directly with Wikidata item

1 reference

20 August 2017

1 reference